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Staphylococcus aureus causes acute and
often fatal infections. Small colony variants
(SCVs), which are subpopulations of S. aureus,
are implicated in persistent and recurrent
infections (in particular osteomyelitis, septic
arthritis, respiratory tract infections in patients
with cystic fibrosis, and deep-seated abscesses)
(1-4). These phenotypic variants produce small,
slow-growing, nonpigmented, nonhemolytic colo-
nies on routine culture media, making correct
identification difficult for clinical laboratories.
Biochemical characterization of these variants
suggests that they are deficient in electron
transport activity (5).
 We report a fatal case of a persistent deep-
seated hip abscess due to methicillin-resistant
S. aureus SCVs that led to osteomyelitis and
bloodstream infection in a patient with AIDS.
Case Report
A 36-year-old man with AIDS came to the
Cologne University Hospital, Cologne, Germany,
in June 1997 with fever and progressive pain (of
6 weeks duration) in his right hip. HIV infection
had been diagnosed in 1986. In 1994, his CD4 cell
count was 250/µL, and oral zidovudine therapy
was started. His medical history included
Pneumocystis carinii pneumonia, pulmonary
tuberculosis, and recurrent oral thrush; his
medication included zidovudine, lamivudine,
fluconazole, and  trimethoprim/sulfamethoxazole.
In September 1996, he was in a traffic accident
and had severe cerebral trauma resulting in
spastic hemiparesis with occasional seizures.
After an intramuscular injection 2 months before
admission, pus was surgically drained to treat
recurrent abscesses of his right hip. Specimens
for culture were not obtained.
Physical examination found limited mobility
of his right thigh and a tender, nondraining scar
at the site of surgical drainage. Neither warmth
nor swelling was observed over his right hip.
Vital signs were temperature, 38.2°C; respira-
tion rate, 28; and heart rate, 108. He was awake
and alert and had spastic paresis in his right
arm.
Laboratory studies performed on admission
showed hemoglobin, 10.8 g/dL; leukocyte count,
3,000/µL with a normal differential; CD4 cell
count, 20/µL; platelet count, 131,000/µL;
C-reactive protein, 184 mg/L; and alkaline
phosphatase, 1490 U/L. Radiographs of the chest
and a plain film of the pelvis were normal. A
triple-phase bone scan showed an area of minor
tracer accumulation in the acetabulum region of
the right hip. Blood cultures were drawn, but
antimicrobial therapy was withheld until culture
results became available.
On hospital day 2, one of two blood cultures
drawn on admission yielded nonhemolytic
staphylococci that were clumping factor
negative. The organisms were initially
misidentified as coagulase-negative staphylo-
cocci and were considered contaminants.
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Figure 1. Staphylococcus aureus small colony
variants (A) and S. aureus with a normal phenotype
(B) cultured on sheep blood agar after 24 hours of
incubation at 35°C. Staphylococci were identified by
conventional methods (6) and with the ID 32 Staph
system (bioMérieux, Marcy-LEtoile, France) follow-
ing the instructions of the manufacturer. The tube-
coagulase test was read after 24 hours. S. aureus
isolates were characterized as small colony variants
as described before (7-8). Auxotrophic requirements
were evaluated with 10-µg hemin disks, 1.5-µg
menadione disks, and 1.5-µg thymidine disks on
Mueller-Hinton agar and on chemically defined
medium (CDM) agar as well as on CDM agar
supplemented with 1 µg/mL hemin, 100 µg/mL
thymidine, and 1 µg/mL menadione, respectively.
Empiric antistaphylococcal therapy with
clindamycin (600 mg q8hr) was instituted. On
hospital day 4, two sets of blood cultures obtained
on hospital day 2 yielded phenotypically
identical organisms, which on the basis of a
positive tube coagulase test were identified as
oxacillin-resistant S. aureus. The colony mor-
phology was suggestive of an SCV of S. aureus.
The patient was started on parenteral vancomy-
cin treatment (1 g q12hr). However, his condition
deteriorated rapidly, and he died of refractory
septic shock 6 days after admission.
Autopsy showed a large (12 x 10 x 8 cm),
deep-seated abscess of the right hip and
osteomyelitis of the ischial tuberosity. Both
SCVs and typical large colony forms of S. aureus
were cultured from postmortem specimens of the
abscess and the bone.
Findings
S. aureus SCVs were recovered from one of
two blood culture sets obtained on admission and
from two of four blood culture sets obtained on
hospital day 2. Growth was not detected until the
blood culture bottles had been incubated 24
hours.  S. aureus with a normal phenotype was
recovered from nose and throat specimens but
not from blood cultures, whereas both SCVs and
typical S. aureus phenotypes were isolated from
the deep hip abscess (Figure 1) before death, as
well as from a postmortem specimen. All isolates
were clumping factornegative but showed a
delayed positive reaction in the tube-coagulase
test at 24 hours. The results of the ID 32 staph
test did not unambiguously identify SCVs as
S. aureus because the tests for urease and
trehalose were negative. Both the nuc gene and
the coa gene were identified by polymerase chain
reaction (PCR) amplification. Methicillin resis-
tance was confirmed for both small and large
colony forms by PCR amplification of the mecA
gene.
When cultured without supplementation, all
SCVs were nonpigmented and nonhemolytic.
Supplementation with hemin, thymidine, or
menadione identified two SCVs showing thymi-
dine auxotrophy and a combined thymidine and
menadione auxotrophy, respectively. All SCVs
were stable on repeated subculturing.
Epidemiologic typing by PCR analysis of
inter-IS256 spacer length polymorphisms (Fig-
ure 2) and pulsed-field gel electrophoresis of
genomic DNA (data not shown) showed identical
banding patterns for both SCVs and large colony
forms, which indicates that the phenotypically
different S. aureus isolates represented a single
strain. Antimicrobial susceptibility testing was
performed by microbroth dilution, according to
the National Committee for Clinical Laboratory
Standards guidelines. Susceptibility to
trimethoprim/sulfamethoxazole was tested with
Etest (AB Biodisk, Solna, Sweden). In contrast to
current standards, the MICs for SCVs were
determined after 48 hours of incubation at 35°C.
Susceptibility testing showed that all S. aureus
isolates were resistant to penicillin (MIC, >8 µg/
mL), ampicillin (MIC, >32 µg/mL), oxacillin
(MIC, >8 µg/mL), erythromycin (MIC, >32 µg/mL),
clindamycin (MIC, >32 µg/mL), ciprofloxacin
(MIC, >8 µg/mL), gentamicin (MIC, >500 µg/mL),
and trimethoprim/sulfamethoxazole (MIC,
>32 µg/mL) and susceptible to vancomycin452 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Figure 2. Fingerprint patterns obtained for
Staphylococcus aureus small colony variants (lanes 3-
5, bloodculture isolates; lanes 6 and 7, isolates from
hip abscess; lane 8, postmortem specimen) and S.
aureus isolates with a normal phenotype (lanes 10
and 11, isolates from nose and throat; lanes 12 and
13, isolates from hip abscess and postmortem
specimen) after polymerase chain reaction (PCR)
analysis of inter-IS256 spacer length showing
identical strains. Lane 1, 100-bp ladder; lanes 2, 9,
and 16, methicillin-resistant S. aureus (MRSA)
reference strain; lanes 14 and 15, epidemiologically
unrelated MRSA strains. Strain relatedness of all
isolates with different colony morphologies and from
different sources was analyzed by PCR analysis of
inter-IS256 spacer length polymorphisms (9) and
pulsed-field gel electrophoresis after SmaI restric-
tion (8). Minor modifications included the use of brain
heart infusion broth instead of trypticase soy broth to
obtain sufficient growth of S. aureus small colony
variants.
(MICs, 1-2 µg/mL), teicoplanin (MICs,
0.5-1 µg/mL), and quinupristin/dalfopristin
(MICs, 0.5-1 µg/mL). No differences in MICs
were observed between S. aureus SCVs and S.
aureus isolates with normal phenotype.
To our knowledge, this case represents the
first of a serious S. aureus infection in an AIDS
patient in which all blood cultures yielded SCVs.
The SCVs unusual morphologic appearance
and slow growth delayed the correct identifica-
tion of these organisms as S. aureus. The
empiric antimicrobial regimen in our patient
did not include a glycopeptide, because of the
low rate of methicillin resistance in commu-
nity-acquired S. aureus infection in Germany.
Appropriate antistaphylococcal therapy was,
therefore, not started until hospital day 4.
Delayed antimicrobial therapy on day 4 rather
than on day 2 may have contributed to the
patients death.
Proctor and colleagues recently reported five
cases in which SCVs of S. aureus were implicated
in persistent and relapsing infections. They
identified only a single case reported in the
previous 17 years and ascribed this to
insufficient ability of laboratories to identify
these organisms (8). In most cases, patients had
received antibiotics. Aminoglycoside treatment
may have selected for S. aureus SCVs (10), and in
cases of osteomyelitis or deep-seated abscesses,
persistence of these variants in the intracellular
milieu may have permitted evasion of host
defenses and allowed for the development of
resistance to antimicrobial therapy (7,11). Von
Eiff and colleagues recently reported four cases
of chronic osteomyelitis due to SCVs of S. aureus
in patients who had received gentamicin beads
as an adjunct to surgical therapy for osteomyeli-
tis (2). Kahl et al. described persistent infection
with  S. aureus SCVs in patients with cystic
fibrosis (4). All these patients had received long-
term trimethoprim/sulfamethoxazole prophy-
laxis. It may be tempting to speculate that
administration of trimethoprim/sulfamethoxazole
for prophylaxis against P. carinii pneumonia
may have selected for SCVs within the patients
large hip abscess. Further prospective studies
are needed to assess the role of S. aureus SCVs in
HIV-infected patients on long-term antimicro-
bial therapy.
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